Psorinum
Psorinum 12C
Approved
Approval ID
86bb3a80-c676-d478-e053-2a91aa0a8c27
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 15, 2023
Manufacturers
FDA
Boiron
DUNS: 282560473
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SCABIES LESION LYSATE (HUMAN)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0220-7624
Product Classification
G
Generic Name
SCABIES LESION LYSATE (HUMAN)
Product Specifications
Route of AdministrationORAL
Effective DateNovember 15, 2023
FDA Product Classification
INGREDIENTS (3)
SUCROSEInactive
Code: C151H8M554
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
SCABIES LESION LYSATE (HUMAN)Active
Quantity: 12 [hp_C] in 12 [hp_C]
Code: 5UAU16Z1U4
Classification: ACTIB